Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 4 Neoplasms 2 Weight Loss 1 Prosthesis Failure 1 Nutrition Disorders 1 Menorrhagia 1 Leiomyoma 1 Endometrial Hyperplasia 1 Adrenocortical Carcinoma 1

Interventions

pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Mitotane 2 fludarabine phosphate 1 dostarlimab 1 Megestrol Acetate 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Floxuridine 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adrenocortical Carcinoma × Megestrol Acetate × Clear all

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡